These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 15726461)

  • 21. Establishing pan-European clinical trials: regulatory compliance and other practical considerations.
    Grienenberger A
    J Biolaw Bus; 2004; 7(4):58-63. PubMed ID: 15675097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GCP inspections in Germany and Europe following the implementation of the Directive 2001/20/EC.
    Göbel C; Baier D; Ruhfus B; Hundt F
    Ger Med Sci; 2009 Mar; 7():Doc01. PubMed ID: 19675741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Changes in the German Medicinal Product Act imposed by the EU regulation on clinical trials].
    Nickel L; Seibel Y; Frech M; Sudhop T
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Aug; 60(8):804-811. PubMed ID: 28664271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Consequences of the 12th AMG amendment on the conduct of non-commercial clinical trials].
    Rossion I
    Urologe A; 2005 Dec; 44(12):1444-8. PubMed ID: 16283155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [ICH-GCP Guideline: quality assurance of clinical trials. Status and perspectives].
    Englev E; Petersen KP
    Ugeskr Laeger; 2003 Apr; 165(16):1659-62. PubMed ID: 12756823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Recommendation for studies of optimizing therapy protocols].
    Creutzig U; Winkler K
    Klin Padiatr; 1994; 206(4):191-3. PubMed ID: 7967415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The 12th amendment to the German Drug Law. Chances and obstacles for investigator-initiated clinical trials].
    Dreier G; Marx C; Schmoor C; Maier-Lenz H
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Apr; 48(4):445-52. PubMed ID: 15830256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Informed consent for paediatric clinical trials in Europe.
    Lepola P; Needham A; Mendum J; Sallabank P; Neubauer D; de Wildt S
    Arch Dis Child; 2016 Nov; 101(11):1017-1025. PubMed ID: 27226526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. WHO Expert Committee on specifications for pharmaceutical preparations.
    World Health Organ Tech Rep Ser; 1996; 863():1-194. PubMed ID: 8952445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical trials for children with cancer in Europe - still a long way from harmonisation: a report from SIOP Europe.
    Pritchard-Jones K;
    Eur J Cancer; 2008 Oct; 44(15):2106-11. PubMed ID: 18757192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical trials in children--between the expectations of scientific requirements, the assurance of proven treatment and ethical demands].
    Lehmann B; Mentzer D; Fischer T; Mallinckrodt-Pape K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2009 Apr; 52(4):410-6. PubMed ID: 19266173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Food and Drug Administration and pragmatic clinical trials of marketed medical products.
    Anderson ML; Griffin J; Goldkind SF; Zeitler EP; Wing L; Al-Khatib SM; Sherman RE
    Clin Trials; 2015 Oct; 12(5):511-9. PubMed ID: 26374684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Standards, guidelines and principles for clinical trials: medical products].
    Ziegler WJ; Perren SM
    Swiss Surg; 1995; (1):81-3. PubMed ID: 8581810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New drugs and European procedures of approval. The European Agency for the Evaluation of Medicinal Products' role].
    Ainsworth MA
    Ugeskr Laeger; 2003 Apr; 165(16):1648-9. PubMed ID: 12756819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Eurocleft project 1996-2000: overview.
    Shaw WC; Semb G; Nelson P; Brattström V; Mølsted K; Prahl-Andersen B; Gundlach KK
    J Craniomaxillofac Surg; 2001 Jun; 29(3):131-40; discussion 141-2. PubMed ID: 11465251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. European Union clinical trials directive.
    Bull Med Ethics; 2001 Jul; (169):13-24. PubMed ID: 11878337
    [No Abstract]   [Full Text] [Related]  

  • 38. Regulatory requirements for clinical trial and marketing authorisation application for gene therapy medicinal products.
    Schüle S; Renner M; Longhurst S; Narayanan G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Jan; 53(1):30-7. PubMed ID: 20012927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical research. Effects of European legislation and current developments].
    Sudhop T; Enzmann H; Klar R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2009 Apr; 52(4):375-6. PubMed ID: 19343281
    [No Abstract]   [Full Text] [Related]  

  • 40. [The national legislation accompanying the approval procedure for clinical trials of medicinal products for human use under Regulation (EU) No. 536/2014].
    Frech M; Dexel F; Burgard M; Seibel Y
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2023 Jan; 66(1):12-20. PubMed ID: 36525035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.